• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,390.16 -112.69
( -0.15%)
Global Indices
Nasdaq
46,970.79 391.31
(0.84%)
Dow Jones
6,721.52 68.33
(1.03%)
Hang Seng
53,729.78 -89.83
(-0.17%)
Nikkei 225
10,338.98 77.83
(0.76%)
Forex
USD-INR
92.32 0.03
(0.03%)
EUR-INR
105.40 -1.04
(-0.98%)
GBP-INR
122.05 -1.31
(-1.06%)
JPY-INR
0.58 0.00
(-0.37%)

EQUITY - MARKET SCREENER

Shilpa Medicare Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
530549
INE790G01031
137.4709721
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SHILPAMED
55.97
6185.28
EPS(TTM)
Face Value()
Div & Yield %
5.65
1
0.16
 

tata motors ltd
IFCI spurts on monetising 10% stake in NEDFi
Dec 31,2025
IFCI said it has monetised its 10% holding in North Eastern Development Finance Corporation Ltd (NEDFi), comprising 1 crore equity shares acquired at a cost of Rs 10 crore, for a total consideration of Rs 121.77 crore.

IFCI is non-banking finance company in the public sector. It provides financial support for the diversified growth of industries across the spectrum. The financing activities cover various kind of projects such as airports, roads, telecom, power, real estate, manufacturing, services sector and such other allied industries.

On a consolidated basis, net profit of IFCI rose 73.03% to Rs 142.96 crore while total income fell 4.27% to Rs 752.21 crore in Q2 September 2025 over Q2 September 2024.